Literature DB >> 19809867

Perceptions of high-risk care and barriers to care among women at risk for hereditary breast and ovarian cancer following genetic counseling in the community setting.

Debra Morgan1, Heather Sylvester, F Lee Lucas, Susan Miesfeldt.   

Abstract

Data are limited regarding barriers to care among women, with or at risk for hereditary breast and ovarian cancer (HBOC), following genetic counseling in the community setting. Using a telephone survey, we retrospectively addressed perceptions of post-genetic counseling medical care and barriers to care among 69 at-risk women from the non-academic setting. Of these, all agreed that following cancer screening recommendations was better than not following them; none felt recommendations were too difficult to follow; all believed screening would help keep them healthy; 57% believed screening would prevent cancer. Twenty-five percent noted discomfort with breast imaging; 29% found ovarian cancer screening uncomfortable. Close to a quarter of participants reported difficulty deciding whether or not to undergo risk-reducing mastectomy while 10% noted difficulty deciding for or against bilateral salpingo-oophorectomy. There were no perceived major barriers to care, although 38% felt that screening reminders would be helpful, and 10% needed more help in following through with care. Overall, participants believed that they were benefiting from their post-genetic counseling medical care. This work identified HBOC-related support needs to include: informational resources that promote improved understanding of cancer risk and high-risk management; screening reminder systems; and decision support tools.

Entities:  

Mesh:

Year:  2009        PMID: 19809867     DOI: 10.1007/s10897-009-9261-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  35 in total

1.  Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results.

Authors:  Lois C Friedman; H Paul Cooper; John A Webb; Armin D Weinberg; Sharon E Plon
Journal:  J Cancer Educ       Date:  2003       Impact factor: 2.037

2.  Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.

Authors:  P Hopwood; F Keeling; A Long; C Pool; G Evans; A Howell
Journal:  Psychooncology       Date:  1998 Sep-Oct       Impact factor: 3.894

3.  Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

Authors:  Jeffrey R Botkin; Ken R Smith; Robert T Croyle; Bonnie J Baty; Jean E Wylie; Debra Dutson; Anna Chan; Heidi A Hamann; Caryn Lerman; Jamie McDonald; Vickie Venne; John H Ward; Elaine Lyon
Journal:  Am J Med Genet A       Date:  2003-04-30       Impact factor: 2.802

4.  Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer.

Authors:  Claudine Isaacs; Beth N Peshkin; Marc Schwartz; Tiffani A Demarco; David Main; Caryn Lerman
Journal:  Breast Cancer Res Treat       Date:  2002-01       Impact factor: 4.872

5.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Authors:  C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch
Journal:  Prev Med       Date:  2000-07       Impact factor: 4.018

6.  Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.

Authors:  Paul A James; Rebecca Doherty; Marion Harris; Bickol N Mukesh; Alvin Milner; Mary-Anne Young; Clare Scott
Journal:  J Clin Oncol       Date:  2006-02-01       Impact factor: 44.544

7.  Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

Authors:  Susan M Domchek; Tara M Friebel; Susan L Neuhausen; Theresa Wagner; Gareth Evans; Claudine Isaacs; Judy E Garber; Mary B Daly; Rosalind Eeles; Ellen Matloff; Gail E Tomlinson; Laura Van't Veer; Henry T Lynch; Olufunmilayo I Olopade; Barbara L Weber; Timothy R Rebbeck
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

8.  The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress.

Authors:  A Cull; E D Anderson; S Campbell; J Mackay; E Smyth; M Steel
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  The impact of genetic counselling on risk perception in women with a family history of breast cancer.

Authors:  D G Evans; V Blair; R Greenhalgh; P Hopwood; A Howell
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.

Authors:  A Fry; A Cull; S Appleton; R Rush; S Holloway; D Gorman; R Cetnarskyj; R Thomas; J Campbell; E Anderson; M Steel; M Porteous; H Campbell
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more
  4 in total

1.  An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data.

Authors:  Stephanie A Cohen; Courtney Lynam Scherr; Dawn M Nixon
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

2.  Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery.

Authors:  Rachel Shapira; Erin Turbitt; Lori H Erby; Barbara B Biesecker; William M P Klein; Gillian W Hooker
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.

Authors:  J Brian Szender; Jasmine Kaur; Katherine Clayback; Mollie L Hutton; June Mikkelson; Kunle Odunsi; Cara Dresbold
Journal:  Int J Gynecol Cancer       Date:  2018-01       Impact factor: 3.437

4.  Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test.

Authors:  Jada G Hamilton; Margaux Genoff Garzon; Ibrahim H Shah; Kechna Cadet; Elyse Shuk; Joy S Westerman; Jennifer L Hay; Kenneth Offit; Mark E Robson
Journal:  Public Health Genomics       Date:  2020-03-19       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.